Related references
Note: Only part of the references are listed.Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study
Marjolein F. Q. Kluytmans-van den Bergh et al.
LANCET INFECTIOUS DISEASES (2019)
Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients: causes and consequences
A. Noel et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Discontinuing contact precautions for multidrug-resistant organisms: A systematic literature review and meta-analysis
Alexandre R. Marra et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2018)
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
Long-term morbidity and mortality following bloodstream infection: A systematic literature review
John F. McNamara et al.
JOURNAL OF INFECTION (2018)
Understanding why resistant bacteria are associated with higher mortality in ICU patients
Francois Barbier et al.
INTENSIVE CARE MEDICINE (2016)
Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs
J. A. Maslikowska et al.
JOURNAL OF HOSPITAL INFECTION (2016)
Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K-pneumoniae and E-coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype
Christian Sakellariou et al.
PLOS ONE (2016)
E-coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality
R. Leistner et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2016)
About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli
Jean-Ralph Zahar et al.
BMC INFECTIOUS DISEASES (2015)
Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013
I. Arnaud et al.
EUROSURVEILLANCE (2015)
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
E. Tacconelli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort
R. Leistner et al.
INFECTION (2014)
Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection
Shawn H. MacVane et al.
JOURNAL OF HOSPITAL MEDICINE (2014)
Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
Steven Z. Kassakian et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience
Anne Carbonnel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
M. E. A. de Kraker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study
Marie-Laurence Lambert et al.
LANCET INFECTIOUS DISEASES (2011)
Curbing Methicillin-Resistant Staphylococcus aureus in 38 French Hospitals Through a 15-Year Institutional Control Program
Vincent Jarlier et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Taking Off the Gloves: Toward a Less Dogmatic Approach to the Use of Contact Isolation
Kathryn B. Kirkland
CLINICAL INFECTIOUS DISEASES (2009)
Increase in hospital-acquired bloodstream infections caused by extended spectrum β-lactamase-producing Escherichia coli in a large French teaching hospital
L. Drieux et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Extension of β-lactamases producing bacteria is a worldwide concern
Jean-Ralph Zahar et al.
M S-MEDECINE SCIENCES (2009)
CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy
Sophie Boyer-Mariotte et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
High rate of intestinal colonization with extended-spectrum-β-lactamase-producing organisms in household contacts of infected community patients
Aranzazu Valverde et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Bacteremias: A leading cause of death
GML Bearman et al.
ARCHIVES OF MEDICAL RESEARCH (2005)
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients
J Rodríguez-Baño et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
